Liberty Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-307
Closed -$182K 1011
2021
Q3
$182K Buy
307
+152
+98% +$83.4K 0.06% 177
2021
Q2
$78K Buy
155
+16
+12% +$7.55K 0.03% 248
2021
Q1
$71K Hold
139
0.03% 226
2020
Q4
$71K Sell
139
-6
-4% -$2.81K 0.03% 224
2020
Q3
$64K Sell
145
-18
-11% -$7.44K 0.04% 203
2020
Q2
$59K Buy
163
+8
+5% +$2.68K 0.04% 203
2020
Q1
$44K Sell
155
-5
-3% -$1.58K 0.04% 227
2019
Q4
$52K Buy
160
+5
+3% +$1.52K 0.04% 240
2019
Q3
$45K Sell
155
-37
-19% -$10.6K 0.04% 247
2019
Q2
$56K Buy
192
+26
+16% +$7.16K 0.05% 232
2019
Q1
$45K Buy
166
+8
+5% +$1.99K 0.03% 212
2018
Q4
$35K Buy
+158
New +$37.1K 0.03% 234

Other funds holding TMO

Liberty Wealth Management's TMO Position: Q4 2021 in Review

Liberty Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 307 shares — an estimated $182K sold.

Liberty Wealth Management first reported a position in TMO in Q4 2018 and held it in 12 quarters. The position peaked at $182K in Q3 2021. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Liberty Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 307 Thermo Fisher Scientific shares in Q4 2021, an estimated $182K.
  • Liberty Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 12 quarters.
  • Liberty Wealth Management's Thermo Fisher Scientific position peaked at $182K in Q3 2021.
  • 2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.